Bayer Plans Heartworm Marketing Campaign For April

The newest consumer marketing campaign launched by Bayer HealthCare LLC’s Animal Health Division aims to encourage any and all pet owners to visit the vet next month.

Bayer Healthcare LLC’s Animal Health Division is launching a consumer marketing campaign to encourage pet owners to visit their veterinarian next month as part of National Heartworm Awareness Month.

Bayer Animal Health will contact owners through a direct mail and email campaign in April that will reach nearly three million pet owners in the U.S., the Shawnee, Kan.-based company said.

Bayer is the manufacturer of the heartworm preventive Advantage Multi for Dogs (imidacloprid and moxidectin) Topical Solution.

“Veterinarians are a dog’s best friend when it comes to preventing heartworm and other pathogenic internal parasites, like hookworms and whipworms,” said Cristiano von Simson, DVM, M.B.A., director of veterinary technical services at Bayer Animal Health. “Veterinarians are experts on dog parasites, such as heartworm, and their ability to both prescribe and dispense preventives increases compliance. When pet owners leave their veterinarian’s office, it is essential that they leave with a medicine they need to protect their dogs from this serious disease.”

<HOME>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

___

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.